Moreover, our discovery of CYSLTR1 and CYSLTR2 as novel prognostic, lymph node and distant metastasis predictive markers provides important evidence for the clinical significance of the expression and methylation profile of these two CysLTRs in patients with CRC. This evidence concerns the gene CYSLTR2 and colorectal carcinoma.